Shirasago Yoshitaka, Sekizuka Tsuyoshi, Saito Kyoko, Suzuki Tetsuro, Wakita Takaji, Hanada Kentaro, Kuroda Makoto, Abe Ryo, Fukasawa Masayoshi
Department of Biochemistry and Cell Biology; Research Institute for Biomedical Sciences, Tokyo University of Science, 278-0022..
Jpn J Infect Dis. 2015;68(2):81-8. doi: 10.7883/yoken.JJID.2014.231. Epub 2014 Nov 25.
An efficient cell culture and infection system for hepatitis C virus (HCV) facilitates analyses of the complete virus life cycle. Human hepatic Huh7.5.1 cells and an HCV-JFH1 strain have been widely employed in infection experiments. In the present study, cultured Huh7.5.1 cells exhibited heterogeneous phenotypes of HCV infection. Using single-cell cloning of Huh7.5.1 cells, we isolated a clone highly permissive to HCV (Huh7.5.1-8) and a CD81-defective clone nonpermissive to HCV (Huh7.5.1-5). Expression of CD81 in Huh7.5.1-5 cells restored permissiveness to HCV, indicating that CD81 is essential for HCV infection and a defect in CD81 causes nonpermissiveness to HCV in Huh7.5.1-5 cells. Huh7.5.1-8 cells had approximately 10-fold higher HCV replication rates, with cellular HCV RNA copy numbers of >10(9) copies/μg of cellular RNA and viral titers of >10(6) infectious units/ml of culture supernatant. Permissiveness of Huh7.5.1-8 cells to HCV infection was phenotypically very stable because there was no difference in permissiveness after more than 100 passages (1-year culture). This efficient cell culture system for HCV using Huh7.5.1-8 cell provides a powerful tool for studying the HCV life cycle and constructing antiviral strategies.
一种高效的丙型肝炎病毒(HCV)细胞培养和感染系统有助于对完整病毒生命周期进行分析。人源肝脏Huh7.5.1细胞和HCV-JFH1毒株已广泛用于感染实验。在本研究中,培养的Huh7.5.1细胞表现出HCV感染的异质表型。通过对Huh7.5.1细胞进行单细胞克隆,我们分离出了一个对HCV高度敏感的克隆(Huh7.5.1-8)和一个对HCV不敏感的CD81缺陷克隆(Huh7.5.1-5)。在Huh7.5.1-5细胞中表达CD81可恢复对HCV的敏感性,这表明CD81对HCV感染至关重要,且CD81缺陷导致Huh7.5.1-5细胞对HCV不敏感。Huh7.5.1-8细胞的HCV复制率高出约10倍,细胞HCV RNA拷贝数>10⁹拷贝/μg细胞RNA,病毒滴度>10⁶感染单位/ml培养上清液。Huh7.5.1-8细胞对HCV感染的敏感性在表型上非常稳定,因为在传代100多次(1年培养)后敏感性没有差异。这种使用Huh7.5.1-8细胞的高效HCV细胞培养系统为研究HCV生命周期和构建抗病毒策略提供了强大工具。